Sign in
4

Changes in Ownership

Edwards Lifesciences Corp Filed Acc 0001225208-26-000558

CVP, TAVR sold 1,019 shares at $85.70 ($87,332)

  • CVP, TAVR acquired 1,019 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Lippis Daniel J. · CVP, TAVR

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-01-09 Exercise or conversion : show line 1 in the form 10b5-1 +1,019 $59.26 $60,383 23,020.91 D
2026-01-09 Sale : show line 2 in the form 10b5-1 −1,019 $85.70 $87,332 22,001.91 D
Open-market sales · 1,019 sh · avg $85.70 · $87,332

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-01-09 Exercise or conversion : show line 3 in the form 10b5-1 Employee Stock Option (Right to Acquire) −1,019 4,076 D
Loading xslF345X05/doc4.xml…